Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation

被引:20
|
作者
Okumura, Fumihiko [6 ]
Lenschow, Deborah J. [3 ,4 ,5 ]
Zhang, Dong-Er [1 ,2 ,6 ]
机构
[1] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA
[2] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, San Diego, CA 92093 USA
[3] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Immunol, St Louis, MO 63110 USA
[6] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1074/jbc.M803795200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of the ubiquitin-like molecule ISG15 (UCRP) and protein modification by ISG15 (ISGylation) are strongly activated by interferon, genotoxic stress, and pathogen infection, suggesting that ISG15 plays an important role in innate immune responses. Inducible nitric-oxide synthase (iNOS) is induced by the similar stimuli as ISG15 and enhances the production of nitric oxide (NO), a pleiotropic free radical with anti-pathogen activity. Here, we report that cysteine residues (Cys-76 and -143 in mouse, Cys-78 in human) of ISG15 can be modified by NO, and the NO modification of ISG15 decreases the dimerization of ISG15. The mutation of the cysteine residue of ISG15 to serine improves total ISGylation. The NO synthase inhibitor S-ethylisothiourea reduces endogenous ISGylation. Furthermore, ectopic expression of iNOS enhanced total ISGylation. Together, these results suggest that nitrosylation of ISG15 enhances target protein ISGylation. This is the first report of a relationship between ISGylation and nitrosylation.
引用
收藏
页码:24484 / 24488
页数:5
相关论文
共 50 条
  • [1] ISG15 and protein ISGylation
    Cong, Xiuli
    Reuter, Brian
    Yan, Ming
    Zhang, Dong-Er
    [J]. CYTOKINE, 2010, 52 (1-2) : 80 - 80
  • [2] ISG15 and ISGylation in Human Diseases
    Mirzalieva, Oygul
    Juncker, Meredith
    Schwartzenburg, Joshua
    Desai, Shyamal
    [J]. CELLS, 2022, 11 (03)
  • [3] The Functional Roles of ISG15/ISGylation in Cancer
    Yuan, Yin
    Qin, Hai
    Li, Huilong
    Shi, Wanjin
    Bao, Lichen
    Xu, Shengtao
    Yin, Jun
    Zheng, Lufeng
    [J]. MOLECULES, 2023, 28 (03):
  • [4] ISG15 and protein ISGylation in innate immune responses
    Zhang, Dong-Er
    [J]. CYTOKINE, 2008, 43 (03) : 234 - 234
  • [5] Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators
    Kim, Ye Ji
    Kim, Eui Tae
    Kim, Young-Eui
    Lee, Myoung Kyu
    Kwon, Ki Mun
    Kim, Keun Il
    Stamminger, Thomas
    Ahn, Jin-Hyun
    [J]. PLOS PATHOGENS, 2016, 12 (08)
  • [6] ISG15 and ISGylation: Emergence in the cytoskeleton dynamic and tumor microenvironment
    Tecalco-Cruz, Angeles C.
    [J]. BIOCELL, 2022, 46 (05) : 1209 - 1213
  • [7] ISG15: In Sickness and in Health
    Hermann, Mark
    Bogunovic, Dusan
    [J]. TRENDS IN IMMUNOLOGY, 2017, 38 (02) : 79 - 93
  • [8] ISG15 and immune diseases
    Jeon, Young Joo
    Yoo, Hee Min
    Chung, Chin Ha
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (05): : 485 - 496
  • [9] ISG15: It's Complicated
    Dzimianski, John V.
    Scholte, Florine E. M.
    Bergeron, Eric
    Pegan, Scott D.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2019, 431 (21) : 4203 - 4216
  • [10] The Antiviral Activities of ISG15
    Morales, David J.
    Lenschow, Deborah J.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2013, 425 (24) : 4995 - 5008